Symmetry Investments’s Hologic HOLX Stock Holding History

Symmetry Investments’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,936	Closed	-$541K	–	209
2024 Q1	$541K	Buy	+6,936	New	+$516K	0.03%	132

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Symmetry Investments's HOLX Position: Q2 2024 in Review

Symmetry Investments sold out of Hologic (HOLX) in Q2 2024, closing a stake of 6,936 shares — an estimated $541K sold.

Symmetry Investments first reported a position in HOLX in Q1 2024 and held it in 1 quarter. The position peaked at $541K in Q1 2024. 703 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

Symmetry Investments reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
Symmetry Investments sold 6,936 Hologic shares in Q2 2024, an estimated $541K.
Symmetry Investments first reported a position in Hologic in Q1 2024 and held it in 1 quarter.
Symmetry Investments's Hologic position peaked at $541K in Q1 2024.
703 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on Symmetry Investments's 13F filing for Q2 2024, filed 13 Aug 2024.